Treatment of eosinophilic esophagitis with mometasone furoate aerosol: a randomised, placebo-controlled phase II study for evaluation of treatment effect on group level including symptom questionnaires.
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2018
Price : $35 *
At a glance
- Drugs Mometasone (Primary)
- Indications Eosinophilic oesophagitis
- Focus Therapeutic Use
- 29 Sep 2018 Status changed from recruiting to discontinued.
- 07 Jun 2014 New source identified and integrated (ClinicalTrials.gov NCT02113267)
- 28 Jan 2014 New trial record